EC Ophthalmology

Review Article Volume 16 Issue 1 - 2024

Ocular Biomarkers for Enhanced Systemic Risk Assessment through Artificial Intelligence

Alejandro Espaillat*

South Florida Eye Institute, Fort Lauderdale, FL, USA

*Corresponding Author: Alejandro Espaillat, South Florida Eye Institute, Fort Lauderdale, FL, USA.
Received: November 13, 2024; Published: December 26, 2024



Integrating ocular biomarkers with artificial intelligence (AI) technologies offers a transformative approach to systemic risk assessment in clinical practice. This article explores the potential of ocular biomarkers as predictive tools for systemic diseases, leveraging AI's robust analytical capabilities. Ocular images, being non-invasive and rich in physiological information, can reveal early signs of systemic conditions such as cardiovascular disease, diabetes, and neurodegenerative disorders. AI-powered algorithms enhance these biomarkers' precision and predictive power, enabling early detection and monitoring of disease states that might otherwise remain undiagnosed until advanced stages. We review state-of-the-art AI methods in analyzing retinal images and other ocular data, highlight significant breakthroughs in automatization, and assess the challenges and ethical considerations of integrating AI in clinical risk assessment. The convergence of these technologies promises to refine individual patient care and advance large-scale public health strategies by facilitating more accurate and timely systemic disease prediction. This paper delineates the current landscape and prospects of ocular biomarker utilization in AI-driven systemic health assessments.

 Keywords: Ocular Biomarkers; Artificial Intelligence; Systemic Risk Assessment; Retinal Imaging; Disease Prediction

  1. Wagner SK., et al. “Insights into systemic disease through retinal imaging-based oculomics”. Translational Vision Science and Technology 2 (2020): 6.
  2. Wagner SK., et al. “AlzEye: longitudinal record-level linkage of ophthalmic imaging and hospital admissions of 353 157 patients in London, UK”. BMJ Open3 (2022): e058552.
  3. Kim DH., et al. “Retinal microvascular signs and disability in the Cardiovascular Health Study”. Archives of Ophthalmology3 (2012): 350-356.
  4. Li H., et al. “Automatic grading of retinal vessel caliber”. IEEE Transactions on Biomedical Engineering 7 (2005): 1352-1355.
  5. Wang JJ., et al. “Retinal vessel diameter and cardiovascular mortality: pooled data analysis from two older populations”. European Heart Journal 16 (2007): 1984-1992.
  6. Wong TY., et al. “Do retinopathy signs in non-diabetic individuals predict the subsequent risk of diabetes?” British Journal of Ophthalmology 3 (2006): 301-303.
  7. Günthner R., et al. “Impaired retinal vessel dilation predicts mortality in end-stage renal disease”. Circulation Research (2019).
  8. McGeechan K., et al. “Meta-analysis: retinal vessel caliber and risk for coronary heart disease”. Annals of Internal Medicine6 (2009): 404-413.
  9. McGeechan K., et al. “Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis”. American Journal of Epidemiology 11 (2009): 1323-1332.
  10. Thomson KL., et al. “A systematic review and meta-analysis of retinal nerve fiber layer change in dementia, using optical coherence tomography”. Alzheimer's and Dementia (Amst)2 (2015): 136-143.
  11. You QS., et al. “Macular vessel density measured with optical coherence tomography angiography and its associations in a large population-based study”. Investigative Ophthalmology and Visual Science 14 (2019): 4830-4837.
  12. Duke-Elder S. “System of ophthalmology”. The ocular adnexa (1974): 1031-1032.
  13. Fujimoto J and Swanson E. “The development, commercialization, and impact of optical coherence tomography”. Investigative Ophthalmology and Visual Science 9 (2016): Oct1-oct13.
  14. Pontikos N., et al. “Comment on: Trends in retina specialist imaging utilization from 2012 to 2016 in the United States medicare fee-for-service population”. American Journal of Ophthalmology 211 (2020): 229.
  15. Poplin R., et al. “Prediction of cardiovascular risk factors from retinal fundus photographs via deep learning”. Nature Biomedical Engineering 3 (2018): 158-164.
  16. Cheung CY., et al. “A deep-learning system for the assessment of cardiovascular disease risk via the measurement of retinal-vessel calibre”. Nature Biomedical Engineering 6 (2021): 498-508.
  17. Deo RC. “Machine learning in medicine”. Circulation20 (2015): 1920-1930.
  18. Noorbakhsh-Sabet N., et al. “Artificial intelligence transforms the future of health care”. American Journal of Medicine 7 (2019): 795-801.
  19. Çetinkaya MB and Duran H. “A detailed and comparative work for retinal vessel segmentation based on the most effective heuristic approaches”. Biomedizinische Technik (Berl) 2 (2021): 181-200.
  20. Schmidt-Erfurth U., et al. “Artificial intelligence in retina”. Progress in Retinal and Eye Research 67 (2018): 1-29.
  21. Gulshan V., et al. “Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs”. Journal of the American Medical Association 22 (2016): 2402-2410.
  22. Decencière E., et al. “Feedback on a publicly distributed image database: the Messidor database”. Image Analysis and Stereology3 (2014): 231-234.
  23. Staal J., et al. “Ridge-based vessel segmentation in color images of the retina”. IEEE Transactions on Medical Imaging 4 (2004): 501-509.
  24. Hoover A., et al. “Locating blood vessels in retinal images by piecewise threshold probing of a matched filter response”. IEEE Transactions on Medical Imaging 3 (2000): 203-210.
  25. Decenciere E., et al. “TeleOphta: Machine learning and image processing methods for teleophthalmology”. IRBM2 (2013): 196-203.
  26. Khan SM., et al. “A global review of publicly available datasets for ophthalmological imaging: barriers to access, usability, and generalizability”. The Lancet Digit Health 1 (2021): e51-e66.
  27. Leishman R. “The eye in general vascular disease: hypertension and arteriosclerosis”. British Journal of Ophthalmology 11 (1957): 641-701.
  28. Parr JC. “Hypertensive generalised narrowing of retinal arteries”. Transactions of the Ophthalmological Society of New Zealand 26 (1974): 55-60.
  29. Parr JC and Spears GF. “Mathematic relationships between the width of a retinal artery and the widths of its branches”. American Journal of Ophthalmology 4 (1974): 478-483.
  30. Parr JC and Spears GF. “General caliber of the retinal arteries expressed as the equivalent width of the central retinal artery”. American Journal of Ophthalmology 4 (1974): 472-477.
  31. Hubbard LD., et al. “Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study”. Ophthalmology12 (1999): 2269-2280.
  32. Cheung CY., et al. “Retinal vascular tortuosity, blood pressure, and cardiovascular risk factors”. Ophthalmology 5 (2011): 812-818.
  33. Sasongko MB., et al. “Retinal vascular tortuosity in persons with diabetes and diabetic retinopathy”. Diabetologia9 (2011): 2409-2416.
  34. Sasongko MB., et al. “Alterations in retinal microvascular geometry in young type 1 diabetes”. Diabetes Care6 (2010): 1331-1336.
  35. Liew G., et al. “Fractal analysis of retinal microvasculature and coronary heart disease mortality”. European Heart Journal 4 (2011): 422-429.
  36. Cheung CY., et al. “Quantitative and qualitative retinal microvascular characteristics and blood pressure”. Journal of Hypertension 7 (2011): 1380-1391.
  37. Patton N., et al. “Retinal image analysis: concepts, applications and potential”. Progress in Retinal and Eye Research 1 (2006): 99-127.
  38. Kawasaki R., et al. “Fractal dimension of the retinal vasculature and risk of stroke: a nested case-control study”. Neurology20 (2011): 1766-1767.
  39. Ding J., et al. “Retinal vascular caliber and the development of hypertension: a meta-analysis of individual participant data”. Journal of Hypertension2 (2014): 207-215.
  40. Wong TY., et al. “Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality”. Survey of Ophthalmology 1 (2001): 59-80.
  41. Kawasaki R., et al. “Retinal vessel diameters and risk of hypertension: the Multiethnic Study of Atherosclerosis”. Journal of Hypertension12 (2009): 2386-2393.
  42. Ponto KA., et al. “Retinal vessel metrics: normative data and their use in systemic hypertension: results from the Gutenberg Health Study”. Journal of Hypertension8 (2017): 1635-1645.
  43. Sng CC., et al. “Retinal vascular fractal and blood pressure in a multiethnic population”. Journal of Hypertension10 (2013): 2036-2042.
  44. Jeganathan VSE., et al. “Effect of blood pressure on the retinal vasculature in a multi-ethnic Asian population”. Hypertension Research11 (2009): 975-982.
  45. Wong TY., et al. “Retinal microvascular abnormalities and 10-year cardiovascular mortality: a population-based case-control study”. Ophthalmology5 (2003): 933-940.
  46. Witt N., et al. “Abnormalities of retinal microvascular structure and risk of mortality from ischemic heart disease and stroke”. Hypertension5 (2006): 975-981.
  47. Liew G., et al. “Retinal vasculature fractal and stroke mortality”. Stroke4 (2021): 1276-1282.
  48. McGeechan K., et al. “Risk prediction of coronary heart disease based on retinal vascular caliber (from the Atherosclerosis Risk In Communities [ARIC] Study)”. The American Journal of Cardiology1 (2008): 58-63.
  49. Wong TY., et al. “Does refractive error influence the association of blood pressure and retinal vessel diameters? The Blue Mountains Eye Study”. American Journal of Ophthalmology6 (2004): 1050-1055.
  50. Xing C., et al. “Genome-wide linkage study of retinal vessel diameters in the Beaver Dam Eye Study”. Hypertension4 (2006): 797-802.
  51. Sun C., et al. “Retinal vascular caliber, blood pressure, and cardiovascular risk factors in an Asian population: the Singapore Malay Eye Study”. Investigative Ophthalmology and Visual Science5 (2008): 1784-1790.
  52. McGrory S., et al. “Towards Standardization of Quantitative Retinal Vascular Parameters: Comparison of SIVA and VAMPIRE Measurements in the Lothian Birth Cohort 1936”. Translational Vision Science and Technology 2 (2018): 12.
  53. Downie E., et al. “Comparison of two free retinal vascular measurement software packages: IVAN and VAMPIRE”. Investigative Ophthalmology and Visual Science7 (2015): 3320.
  54. Mautuit T., et al. “Comparing measurements of vascular diameter using adaptative optics imaging and conventional fundus imaging”. Diagnostics3 (2022): 705.
  55. Krestanova A., et al. “Recent techniques and trends for retinal blood vessel extraction and tortuosity evaluation: a comprehensive review”. IEEE Access 8 (2020): 197787-816.
  56. Guo S., et al. “BTS-DSN: Deeply supervised neural network with short connections for retinal vessel segmentation”. International Journal of Medical Informatics 126 (2019): 105-113.
  57. Kim G., et al. “Integrated deep learning framework for accelerated optical coherence tomography angiography”. Scientific Reports1 (2022): 1289.
  58. Hasan MK., et al. “DRNet: Segmentation and localization of optic disc and Fovea from diabetic retinopathy image”. Artificial Intelligence in Medicine 111 (2021): 102001.
  59. Tang S., et al. “U-net with hierarchical bottleneck attention for landmark detection in fundus images of the degenerated retina”. Ophthalmic Medical Image Analysis: 8th International Workshop, OMIA 2021, Held in Conjunction with MICCAI 2021, Strasbourg, France, September 27, 2021, Proceedings 8 2021: Springer (2021).
  60. Ronneberger O., et al. “U-net: Convolutional networks for biomedical image segmentation”. Medical image computing and computer-assisted intervention–MICCAI 2015: 18th international conference, Munich, Germany, October 5-9, 2015, proceedings, part III 18 2015: Springer (2015).
  61. Mou L., et al. “Dense dilated network with probability regularized walk for vessel detection”. IEEE Transactions on Medical Imaging5 (2019): 1392-1403.
  62. Yue K., et al. “Retinal vessel segmentation using dense U-net with multiscale inputs”. Journal of Medical Imaging3 (2019): 034004.
  63. Huang Z., et al. “Automatic Retinal Vessel Segmentation Based on an Improved U-Net Approach”. Scientific Programming (2021): 5520407.
  64. Du XF., et al. “UNet retinal blood vessel segmentation algorithm based on improved pyramid pooling method and attention mechanism”. Physics in Medicine and Biology 17 (2021).
  65. Liu C., et al. “Multiscale U-net with spatial positional attention for retinal vessel segmentation”. Journal of Healthcare Engineering (2022): 5188362.
  66. Yan Z., et al. “A three-stage deep learning model for accurate retinal vessel segmentation”. IEEE Journal of Biomedical and Health Informatics 4 (2018): 1427-1436.
  67. Cao H., et al. “Swin-unet: Unet-like pure transformer for medical image segmentation”. European conference on computer vision 2022: Springer (2022).
  68. Chen D., et al. “PCAT-UNet: UNet-like network fused convolution and transformer for retinal vessel segmentation”. PloS one1 (2022): e0262689.
  69. Welikala R., et al. “Automated arteriole and venule classification using deep learning for retinal images from the UK Biobank cohort”. Computers in Biology and Medicine 90 (2017): 23-32.
  70. Tapp RJ., et al. “Associations of retinal microvascular diameters and tortuosity with blood pressure and arterial stiffness: United Kingdom Biobank”. Hypertension6 (2019): 1383-1390.
  71. Nguyen T. “ChatGPT in Medical Education: A Precursor for Automation Bias?” JMIR Medical Education 10 (2024): e50174.
  72. Bright R. “Tubular view of the morbit appearance in 100 cases connected with albuminous urine with observations”. Guy's Hospital Reports 1 (1836): 380-400.
  73. Gunn R. “Ophthalmoscopic evidence of (1) arterial changes associated with chronic renal disease, and (2) of increased arterial tension”. Transactions of the Ophthalmological Society of the United Kingdom 12 (1892): 124-125.
  74. Keith NM., et al. “Some different types of essential hypertension”. The American Journal of the Medical Sciences3 (1939): 332-343.
  75. Organization WH. “Global health estimates 2016: deaths by cause, age, sex, by country and by region, 2000–2016”. Geneva: World Health Organization (2018): 1242-1247.
  76. Arnett DK., et al. “2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines”. Circulation11 (2019): e563-e595.
  77. Ridker PM and Cook NR. “Statins: new American guidelines for prevention of cardiovascular disease”. The Lancet9907 (2013): 1762-1765.
  78. Kuragaichi T., et al. “External validation of pooled cohort equations using systolic blood pressure intervention trial data”. BMC Research Notes 12 (2019): 271.
  79. Enoch J., et al. “Evaluating whether sight is the most valued sense”. JAMA Ophthalmology11 (2019): 1317-1320.
  80. Robson J., et al. “The NHS Health Check in England: an evaluation of the first 4 years”. BMJ Open1 (2016): e008840.
  81. Krittanawong C., et al. “Deep learning for cardiovascular medicine: a practical primer”. European Heart Journal25 (2019): 2058-2073.
  82. Arnould L., et al. “Prediction of cardiovascular parameters with supervised machine learning from Singapore "I" vessel assessment and OCT-angiography: a pilot study”. Translational Vision Science and Technology 13 (2021): 20.
  83. Kim YD., et al. “Effects of hypertension, diabetes, and smoking on age and sex prediction from retinal fundus images”. Scientific Reports1 (2020): 4623.
  84. Niccoli T and Partridge L. “Ageing as a risk factor for disease”. Current Biology 17 (2012): R741-R752.
  85. Nusinovici S., et al. “Retinal photograph-based deep learning predicts biological age, and stratifies morbidity and mortality risk”. Age and Ageing4 (2022): afac065.
  86. Anderson KM., et al. “An updated coronary risk profile. A statement for health professionals”. Circulation1 (1991): 356-362.
  87. Goff DC Jr., et al. “2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines”. Journal of the American College of Cardiology 25 (2014): 2935-2959.
  88. Detrano R., et al. “Coronary calcium as a predictor of coronary events in four racial or ethnic groups”. New England Journal of Medicine13 (2008): 1336-1345.
  89. Arnould L., et al. “The EYE-MI pilot study: a prospective acute coronary syndrome cohort evaluated with retinal optical coherence tomography angiography”. Investigative Ophthalmology and Visual Science 10 (2018): 4299-4306.
  90. Spaide RF., et al. “Optical coherence tomography angiography”. Progress in Retinal and Eye Research 64 (2018): 1-55.
  91. Chua J., et al. “Impact of hypertension on retinal capillary microvasculature using optical coherence tomographic angiography”. Journal of Hypertension3 (2019): 572-580.
  92. Alan G., et al. “Retinal vascular density as a novel biomarker of acute renal injury after acute coronary syndrome”. Scientific Reports1 (2019): 8060.
  93. Yang D., et al. “A multitask deep-learning system for assessment of diabetic macular ischemia on optical coherence tomography angiography images”. Retina1 (2022): 184-194.
  94. Gao M., et al. “A deep learning network for classifying arteries and veins in montaged widefield OCT angiograms”. Ophthalmology Science2 (2022): 100149.

Alejandro Espaillat. "Ocular Biomarkers for Enhanced Systemic Risk Assessment through Artificial Intelligence." EC Ophthalmology 16.1 (2024): 01-11.